[SGMO] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
08-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 22.82%
YoY- -3.96%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 17,548 8,071 26,837 23,562 21,416 12,637 13,077 21.72%
PBT -30,356 -42,203 -19,219 -12,843 -16,640 -20,187 -13,091 75.46%
Tax -72 -53 -1,246 0 0 -588 -468 -71.38%
NP -30,284 -42,150 -18,664 -12,843 -16,640 -20,187 -13,091 75.18%
Tax Rate - - - - - - - -
Total Cost 47,832 50,221 45,501 36,405 38,056 32,824 26,168 49.66%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -172.58 -522.24 -69.55 -54.51 -77.70 -159.75 -100.11 43.91%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.26 -0.41 -0.18 -0.13 -0.17 -0.23 -0.15 44.44%
EPS Diluted -0.26 -0.41 -0.18 -0.13 -0.17 -0.23 -0.15 44.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.